Kadence Bio Selected for Zcube-Zambon Research Venture's Open Accelerator

Milan, Italy – September 23, 2024 – Kadence Bio is pleased to announce our selection for the fifth edition of Open Accelerator, an international life sciences acceleration program by Zcube-Zambon Research Venture, dedicated to advancing women’s health. Starting today at the OpenZone scientific campus in Milan, we are excited to embark on this journey of growth, opportunity, and networking.

At Kadence Bio, we are committed to addressing the orgasm gap and enhancing overall sexual well-being. Our mission involves developing the first FDA-approved treatment for premature ejaculation, aiming to extend the time to climax for male patients, thus improving relationship health for their partners. We believe that fostering mutual sexual satisfaction can significantly impact quality of life and relationship dynamics, making the program's emphasis on women’s health particularly relevant to our objectives.

The Open Accelerator program is designed to support innovative projects in the life sciences sector, offering tailored mentorship, networking opportunities, and access to resources that can help accelerate our development. Zcube, the research venture of the Zambon Group, has a strong track record of nurturing startups that drive healthcare innovation, particularly in areas that address unmet medical needs.

We are looking forward to collaborating with other startups and industry experts during this program, leveraging insights and resources to advance our mission in sexual and mental health. Thank you to the Zcube-Zambon team for this opportunity to contribute to meaningful change in women’s health.

Stay connected with Kadence Bio for updates on our progress and initiatives throughout the Open Accelerator program.

Representatives from all five start-ups in the fifth edition of the Open Accelerator program on kick-off day, including Leonie, our Director of Strategy and Operations!